Catalyst Wire Dossier Catalyst Wire Dossier

64Cu-SARTATE

Copper-64 SARTATE · Clarity Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-SARTATE, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO) [Phase 2]

See pricing